Opportunities for Harold Hamm Diabetes Center members include funding awards
and access to
core facilities. A variety of funding awards are available to members to encourage the
further development of their work. Award applications are evaluated on
a competitive, peer-reviewed basis by the Harold Hamm Research Grants
Committee and External Review Panel. Additional awards, such as matching
awards to other funding opportunities, will be announced if they become
available.
Spring 2024 Award Opportunities
Funding Opportunity Summary
The Harold Hamm Diabetes Center (HHDC) is pleased to announce pilot funding
opportunities for 2024. The HHDC Pilot Program will consider funding six
types of proposals including Team Science proposals, Novel Pilot Projects,
Novel Pilot Projects for Post-Docs, Bridge Funding, Equipment Grants and
a Travel Reimbursement. Based on a matching gift, the HHDC will award
up to $1.6M to researchers to launch investigations for Diabetes research.
These funds will be augmented with a collaboration with the Stephenson
Cancer Center for projects specifically aimed at collaboration between
researchers in diabetes and cancer for the following grant modalities:
Team Science and Novel Pilot.
Key Information
HHDC Funded Programs:
Team Science Grant: $100,000 per year for up to 3 years
Novel Pilot Project Grant: $70,000 for up to 2 years
Novel Pilot Project Grant for Post-Docs: $70,000 per year for up to 2 years
Bridge Grant: $100,000 for 1 year
Equipment Grant: Up to $250,000
Travel Reimbursement: Up to $2,500
HHDC-SCC Funded Programs:
Team Science Grant: $100,000 per year up to 3 years
Novel Pilot Project Grant: $70,000 per year for up to 2 years
Funding Priorities:
Applications should be closely aligned with the mission of the HHDC to
increase understanding about the causes and consequences of diabetes and
closely related cardiometabolic conditions like obesity, liver disease,
and cancer, as well as strategies for prevention or treatment of these
conditions. Additionally, proposals that address one or more of the following
themes are HHDC funding priorities:
Theme 1:
Diabetes and Obesity, origins within the first 1000 days of life or changes
across the lifespan. These are proposals that aim to gain basic science and clinical knowledge
on the inter-relationship of obesity and diabetes during fetal development
and early life, or across the lifespan. For example, we are interested
in studies of the genetic, epigenetic, and environmental basis of susceptibility
to developing insulin resistance, metabolic dysregulation, inflammation,
macrovascular and microvascular diabetic complications, obesity, and diabetes.
Theme 2: Translational Research. We encourage new collaborative projects between a Principal Investigator
(PI) who is a basic scientist and a PI who is a clinician or clinical
scientist. These projects must focus on patients or patient samples. At
least one of the two collaborating PIs must be from the College of Medicine.
If you are applying for this paired Basic/Clinical award, please specify
this within the Letter of Intent, and detail the roles of the collaborators.
Theme 3:
Clinical Research/Public Health. We seek proposals to investigate new treatments, interventions, and technology
for diabetes management, along with strategies to raise awareness, promote
prevention, or improve diabetes care. Proposals that address health disparities
related to diabetes, and early stage clinical investigators are particularly
encouraged.
It is strongly anticipated that the results of these pilot projects will
eventually permit investigators to compete successfully for extramural
sources of research support such as the NIH, American Diabetes Association,
JDRF, etc.
Eligibility
The PI of any HHDC grant application must be a Member of the HHDC; the
co-investigators do not have to be members at the time of application
but if successful are encouraged to become Members or Associate Members
of the HHDC during the tenure of the grant. Recipients of
active HHDC grants may not apply for, or hold another HHDC grant or Team Science
grant as project PI or MPI.
Application Process
Letter of Intent
Letter of Intents are due to
HHDCGrants@ouhsc.edu by
5 p.m. on January 12, 2024. Applications selected for full application submission will be notified
by January 31, 2024. The projected start date for the award will be July 1, 2024.
Please see the templates below for grant-specific submission requirements.
Full Application
Application attachments will vary by proposal type. Please see grant specific
instructions below for further information.
In accordance with OUHSC policy, a SoonerTrack routing form should be submitted
at least three full business days prior to the March 19, 2024 grant application deadline. Applicants are expected to work with their assigned Sponsored Program
Administrator (SPA) for review of the application.
Once the review is complete, the Face Page of the application must be signed
by the ORA Official (or equivalent signing official at institutions other
than OUHSC) before the PI submits the final application to HHDC.
External Applicants will need to use their own institution’s offices for any grant processing,
and comply with the March 19, 2024 grant application deadline above.
Submission and Review of Final Application
Send the final application by e-mail to
HHDCGrants@ouhsc.edu no later than 5 p.m. on Tuesday,
March 19, 2024. Please title the application attached to the email: HHDC <Type of Grant>
Grant-[PI Last Name, First Name].
Please submit the application as a single file in pdf format. Failure to follow these steps could cause your application to be overlooked
and not reviewed by the HHDC Grants Review Committee.
The HHDC Grants Review Committee will review and award grants in consultation
with two outside reviewers and one internal reviewer. Outside reviewers
will be specifically selected for each application, for their relevant
subject matter expertise. Applicants are required to provide the names
of three potential outside reviewers in their LOI. The list should consist
of people who are able to provide an unbiaised, objective assessment of
the proposal; however, reviewers should not be current or former mentors,
collaborators, or trainees of the PI or co-investigators. External reviewers
should be at institutions outside of Oklahoma but within the United States.
Final selection of the outside reviewers will be made by the HHDC Grants
Review Committee. Once appointed, the internal committee and panel of
outside reviewers will evaluate the proposal to come to a funding decision.
Program Application and Deadlines
All applications will follow the HHDC Application Form, Terms and Guidelines
found here:
Pediatric Diabetes & Endocrinology, Diabetes & EndocrinologyTulsa, OKView Profile
4.7 out of 5
.png)
